Andrew J. Schwab net worth and biography

Andrew Schwab Biography and Net Worth

Director of CAMP4 Therapeutics

Andy Schwab is a Founder and Managing Partner of 5AM Ventures.

Prior to founding 5AM, Mr. Schwab was a Principal at Bay City Capital where he was involved with companies such as Cubist, PTC Therapeutics, and Syrrx. Previously, he served as Vice President of Business Development at Digital Gene Technologies and as a Vice President in the life science investment banking group of Montgomery Securities. At 5AM, he has led the firm’s investments in and served on the Boards of CAMP4 Therapeutics, DVS (acquired by Fluidigm), Enliven, Escient Pharmaceuticals (Incyte), Flexion Therapeutics (Pacira), Ikaria (Mallinckrodt), Ilypsa (Amgen), Precision NanoSystems (Danaher), Radionetics, RareCyte, Scientist.com (GHO Capital), Skye Bioscience, and TMRW. Mr. Schwab has also served on the Boards of Trustees of the California Academy of Sciences, Davidson College, and the National Venture Capital Association.

Mr. Schwab received a B.S. with Honors in Genetics & Ethics from Davidson College and was a member of its 1992 Final Four soccer team.

What is Andrew J. Schwab's net worth?: The estimated net worth of Andrew J. Schwab is at least $10.51 million as of August 21st, 2026. Schwab owns 2,433,280 shares of CAMP4 Therapeutics stock worth more than $10,511,770 as of August 24th. This net worth estimate does not reflect any other investments that Schwab may own. Learn More about Andrew J. Schwab's net worth.
How do I contact Andrew J. Schwab?: The corporate mailing address for Schwab and other CAMP4 Therapeutics executives is 15635 Alton Parkway Suite 250, Irvine CA, 92618. CAMP4 Therapeutics can also be reached via phone at (949) 600-5600 and via email at [email protected]. Learn More on Andrew J. Schwab's contact information.
Has Andrew J. Schwab been buying or selling shares of CAMP4 Therapeutics?: During the past quarter, Andrew J. Schwab has sold $879,718.72 in shares of CAMP4 Therapeutics stock. Most recently, Andrew J. Schwab sold 32,018 shares of the business's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $4.50, for a transaction totalling $144,081.00. Following the completion of the sale, the director now directly owns 2,433,280 shares of the company's stock, valued at $10,949,760. Learn More on Andrew J. Schwab's trading history.
Who are CAMP4 Therapeutics' active insiders?: CAMP4 Therapeutics' insider roster includes Kurtis Binder (CFO), Jeffery Gardner (CEO), Kelly Gold (Chief Financial Officer), Josh Mandel-Brehm (President & Chief Executive Officer), Yuri Maricich (Chief Medical Officer), Amir Nashat (Director), Andrew Schwab (Director), and Richard Young (Director). Learn More on CAMP4 Therapeutics' active insiders.
Are insiders buying or selling shares of CAMP4 Therapeutics?: During the last twelve months, CAMP4 Therapeutics insiders bought shares 11 times. They purchased a total of 5,624,916 shares worth more than $8,614,444.92. During the last twelve months, insiders at the Wireless communications provider sold shares 4 times. They sold a total of 193,603 shares worth more than $887,991.60. The most recent insider tranaction occured on August, 21st when Director Andrew J Schwab sold 32,018 shares worth more than $144,081.00. Insiders at CAMP4 Therapeutics own 21.7% of the company. Learn More about insider trades at CAMP4 Therapeutics.
Information on this page was last updated on 8/21/2026.

Andrew J. Schwab Insider Trading History at CAMP4 Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/21/2026	Sell	32,018	$4.50	$144,081.00	2,433,280
8/20/2026	Sell	114,700	$4.54	$520,738.00	2,465,298
8/19/2026	Sell	45,147	$4.76	$214,899.72	2,579,998

Andrew J. Schwab Buying and Selling Activity at CAMP4 Therapeutics

CAMP4 Therapeutics Company Overview

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location. The company also offers telematics products, including asset tracking units, mobile telematics devices, fixed and mobile wireless gateways, and routers; and advanced telematics products for the broader connected vehicle and Internet of Things marketplace, which enable customers to optimize their operations by collecting, monitoring, and reporting business-critical information and desired intelligence from remote and mobile assets. In addition, it offers professional services, including project management, engineering services, and installation services. The company sells its products and services to customers in the automotive, telecommunications, industrial equipment, transportation and logistics, government and municipalities, insurance, original equipment manufacturers, and leasing companies. It markets through direct sales organization, channel partner program, original equipment manufacturers, and independent sales representatives and distributors, as well as its websites and digital platform. The company was incorporated in 1981 and is headquartered in Irvine, California.

Today's Range

Now: $4.32

$4.26

$4.52

50 Day Range

MA: $4.12

$3.01

$5.44

2 Week Range

Now: $4.32

$1.41

$7.75

Volume

109,475 shs

Average Volume

183,507 shs

Market Capitalization

$271.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22